Search results
Results From The WOW.Com Content Network
This is the list of Schedule I controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a high potential for abuse. The drug or other substance has no currently accepted medical use in ...
Major depressive episode. A major depressive episode ( MDE) is a period characterized by symptoms of major depressive disorder. Those affected primarily exhibit a depressive mood for at least two weeks or more, and a loss of interest or pleasure in everyday activities. Other symptoms can include feelings of emptiness, hopelessness, anxiety ...
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.
Sertraline (Zoloft) Paroxetine (Paxil) Citalopram (Celexa) SSRIs (short for selective serotonin reuptake inhibitors) boost your serotonin levels. Many healthcare professionals consider them a ...
Like other SSRIs, sertraline can cause a range of possible side effects that typically occur during the first few weeks of treatment, including: Nausea. Fatigue and tiredness. Intimacy problems ...
In Wikidata. Selective serotonin reuptake inhibitors ( SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions. SSRIs increase the extracellular level of the neurotransmitter serotonin by limiting its reabsorption (reuptake) into ...
Trazodone is usually used at a dosage of 150 to 300 mg/day for the treatment of depression. Lower doses have also been used to augment other antidepressants or when initiating therapy. Higher doses, up to 600 mg/day, have been used in more severe cases of depression (in hospitalized patients, for example).
Sensorineural hearing loss ( SNHL) is a type of hearing loss in which the root cause lies in the inner ear, sensory organ ( cochlea and associated structures), or the vestibulocochlear nerve ( cranial nerve VIII). SNHL accounts for about 90% of reported hearing loss. [citation needed] SNHL is usually permanent and can be mild, moderate, severe ...